Beck Mack & Oliver LLC Novartis Ag Transaction History

Beck Mack & Oliver LLC

$4.44 Billion
Q3 2024

A detailed history of Beck Mack & Oliver LLC transactions in Novartis Ag stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 3,800 shares of NVS stock, worth $376,504. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,800

Previous 3,800 -0.0%

Holding current value

$376,504

Previous $404,000 8.17%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $37,028 - $42,948	-400 Reduced 9.52%	3,800 $404,000
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $74,610 - $87,260	-1,000 Reduced 19.23%	4,200 $319,000
Q2 2021 Jul 28, 2021	SELL	$85.24 - $94.15 $42,620 - $47,075	-500 Reduced 8.77%	5,200 $474,000
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $12,525 - $14,770	-150 Reduced 2.56%	5,700 $487,000
Q4 2020 Feb 10, 2021	SELL	$78.07 - $94.43 $2,810 - $3,399	-36 Reduced 0.61%	5,850 $552,000
Q2 2020 Aug 10, 2020	BUY	$80.93 - $91.1 $80,930 - $91,100	1,000 Added 20.47%	5,886 $514,000
Q4 2019 Feb 07, 2020	SELL	$84.35 - $95.37 $6,157 - $6,962	-73 Reduced 1.47%	4,886 $463,000
Q3 2019 Nov 06, 2019	BUY	$85.54 - $94.26 $9,323 - $10,274	109 Added 2.25%	4,959 $431,000
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $278,980 - $343,360	-3,700 Reduced 43.27%	4,850 $443,000
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $63,361 - $68,012	-876 Reduced 9.29%	8,550 $0
Q3 2017 Oct 27, 2017	BUY	$74.14 - $77.27 $698,843 - $728,347	9,426	9,426 $0

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.

Account

Beck Mack & Oliver LLC Novartis Ag Transaction History